Ryan j sullivan (18 Ergebnisse)

Paperback. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. Ryan Merkle (illustrator).

Zustand: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc. Ryan Merkle (illustrator).

Zustand: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 180 pages. 5.50x0.41x8.50 inches. In Stock.

Hardcover. Zustand: Brand New. 180 pages. 5.50x0.60x8.50 inches. In Stock.

Hardcover. Zustand: Good. Zustand des Schutzumschlags: Very Good. xiii, 322 p., [16] p. of plates (1 fold-out) : ill. ; 25 cm. ; ISBN: 0060103361; 9780060103361 LCCN: 73-4061 ; OCLC: 677300 ; LC: E184.I6; Dewey: 917.3/06/9162; B ; beige cloth with gold lettering in photographic dustjacket ; Contents : The F.I.F.'s -- What happened? -- In the beginning -- Everything but the light bulb -- Murray Bay -- Mr. McDonnell's Gimmick -- The greatest nose count of them all -- The original butter-and-egg man -- The wedding of the century -- The wheeler-dealers -- Ma and Pa D -- The bubble breaks -- The decline of Mr. Fall -- The silver kings -- Mr. Ryan's fortune --- And for my eldest son, one set of pearl studs -- The troubles of one house -- Why don't the nice people like us? -- High Society -- The Duchess Brady -- Atomic Tom -- The Buckley's of Great Elm -- The upward climb -- Sons of the priory, daughters of the Sacred Heart -- Royalty -- What did happen -- Problems in the back office -- To the bitter end -- Aftermath -- Robert the roue ; spotting on froe-edge ; otherwise G/VG. Book.…

Zustand: Used. pp. 212.

Zustand: Used. pp. 212.

Taschenbuch. Zustand: Neu. Neuware - The Fine Print of the PhD: What They Don't Tell You Before You SignBefore you spend the next three to seven years earning a PhD, make sure you understand the deal.A PhD can open extraordinary doors-but it can also cost you years of income, career flexibility, relationships, geographic freedom, and opportunities you may never get back.Yet most prospective students make the decision based on rankings, research interests, funding packages, and the excitement of being accepted.That's only the beginning of the story.The Fine Print of the PhD takes a candid, practical look at what happens after you say yes-and the questions you should be asking before you sign.Is a PhD actually worth it That depends.Worth it financially Worth it professionally Worth the time Worth the opportunity cost Worth the risk The answer isn't the same for everyone.Drawing on firsthand experience, decision-making principles, financial analysis, and the realities of doctoral training, this book helps you evaluate the PhD as a major life and career investment-not simply an academic achievement.Inside, you'll explore questions such as: - What is the true financial cost of spending years in graduate school - How much income might you give up while earning your degree - Does 'fully funded' mean what you think it means - How much control does your advisor actually have over your future - What happens if your advisor leaves, your funding changes, or your research doesn't work - How long will the degree realistically take-not just on paper - What happens if you don't finish - What careers are realistically available after graduation - When does a PhD make more sense than staying in industry - How should you compare two competing PhD offers - What questions should you ask a program before accepting its offer This isn't an argument against getting a PhD.It's an argument for knowing what you're signing up for.A doctorate can be one of the most rewarding investments you ever make. It can also be a poor fit if the degree, career path, financial trade-offs, and personal sacrifices don't align with your goals.The difference often comes down to asking better questions before you begin.Whether you're a college student considering graduate school, a master's student deciding whether to continue, a professional contemplating a career change, or someone holding a PhD offer in your hands right now, The Fine Print of the PhD gives you a framework for thinking through the decision with clearer eyes.Don't choose a PhD because everyone around you says you should.Don't reject one because someone else says it's a bad idea.Understand the fine print. Then make the decision for yourself. …

96 pp.; 26.9 x 24 cm.; glue bound; black-and-white & color; edition size unknown; unsigned and unnumbered; offset-printed; Issue no. 67 of the periodical "art / text," edited by Susan Kandel. Contents include: "Lobby: Dinner at Frank's," by Liam Gillick; "Torpor: Deep Chaos," by Chris Kraus; "User: Wireless Cosmopolitans," by Peter Lunenfeld; "Report: 48th Venice Biennale," by Barry Schwabsky; "SITE: Santa Fe Third International Biennial," by Ellen Berkovitch; "TYPE: Professional Me," by Frances Stark; "APROPOS: Smithson, Shakespeare & Satan," by Robert Linsley; "Sally Elesby: Life is a Verb," by Sue Spaid; "Raafat Ishak: Personal Archive," by D.J. Huppatz; "Shaun Kirby: Slow Crawl of Necessity," by Stephen O'Connell; "The Red Eye," art by Jeremy Blake, text by Theresa Duncan; American Psychos: The End of Art Cinema in the '90s," by Laurence A. Rickels; "Thomas Demand: Paper Chases," by Nancy Princenthal; "Doug Aitkin: Immoral Video," by David Hunt; "The Family Firm: Andreas Gursky & German Photography," by Norman Bryson Reviews by Alex Coles, Jan Tumlir, David Hunt, Mai-Thu Perret, Fabrice Stroun, Jeffrey Kastner, Stuart Koop, Charles LaBelle, Ryan Whyte, Michelle Grabner, Barry Schwabsky, Terry R. Myers, Julie Joyce, Peter Frank, Roger Sullivan, Stephen O'Connell, Blair French, Regine Basha, Charles Green, Juliana Engberg, Ihor Holubizky, Lars Bang Larsen, and Gavin Wade. Cover: Thomas Demand. Very Good. Dust soiling of covers with original pricing sticker on bottom left corner of recto. Rubbing and dust soiling of verso. Light edgewear with bumping of top left corner of verso. Contents clean and unmarked. …

Zustand: New. In.

Zustand: New. In.

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 204 pages. 9.25x6.25x0.75 inches. In Stock.

Zustand: New. BRAF Targets in Melanoma Editor(s): Sullivan, Ryan J. Series: Cancer Drug Discovery and Development. Num Pages: 212 pages, 5 black & white illustrations, 21 colour illustrations, 5 black & white tables, biography. BIC Classification: MJCL; MJK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 13. Weight in Grams: 485. . 2014. 2015th Edition. hardcover. . . . . Books ship from the US and Ireland. …

Zustand: New.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.…